BioSyent Statistics
Total Valuation
BioSyent has a market cap or net worth of $88.36 million. The enterprise value is $71.85 million.
| Market Cap | 88.36M |
| Enterprise Value | 71.85M |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | May 31, 2024 |
Share Statistics
BioSyent has 11.80 million shares outstanding. The number of shares has decreased by -3.82% in one year.
| Shares Outstanding | 11.80M |
| Shares Change (YoY) | -3.82% |
| Shares Change (QoQ) | +1.11% |
| Owned by Insiders (%) | 38.45% |
| Owned by Institutions (%) | 1.37% |
| Float | 8.99M |
Valuation Ratios
The trailing PE ratio is 17.31 and the forward PE ratio is 18.36.
| PE Ratio | 17.31 |
| Forward PE | 18.36 |
| PS Ratio | 3.67 |
| Forward PS | 3.20 |
| PB Ratio | 3.49 |
| P/FCF Ratio | 24.14 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 10.64, with an EV/FCF ratio of 19.63.
| EV / Earnings | 13.89 |
| EV / Sales | 2.98 |
| EV / EBITDA | 10.64 |
| EV / EBIT | 11.20 |
| EV / FCF | 19.63 |
Financial Position
The company has a current ratio of 7.72, with a Debt / Equity ratio of 0.03.
| Current Ratio | 7.72 |
| Quick Ratio | 6.24 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | 0.13 |
| Debt / FCF | 0.24 |
| Interest Coverage | -7.37 |
Financial Efficiency
Return on equity (ROE) is 20.41% and return on invested capital (ROIC) is 17.20%.
| Return on Equity (ROE) | 20.41% |
| Return on Assets (ROA) | 17.64% |
| Return on Capital (ROIC) | 17.20% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.81 |
| Inventory Turnover | 1.28 |
Taxes
In the past 12 months, BioSyent has paid $1.68 million in taxes.
| Income Tax | 1.68M |
| Effective Tax Rate | 24.49% |
Stock Price Statistics
The stock price has increased by +35.94% in the last 52 weeks. The beta is 0.95, so BioSyent's price volatility has been similar to the market average.
| Beta (5Y) | 0.95 |
| 52-Week Price Change | +35.94% |
| 50-Day Moving Average | 6.71 |
| 200-Day Moving Average | 6.35 |
| Relative Strength Index (RSI) | 68.08 |
| Average Volume (20 Days) | 812 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BioSyent had revenue of $24.08 million and earned $5.17 million in profits. Earnings per share was $0.43.
| Revenue | 24.08M |
| Gross Profit | 19.19M |
| Operating Income | 5.97M |
| Pretax Income | 6.85M |
| Net Income | 5.17M |
| EBITDA | 6.75M |
| EBIT | 6.42M |
| Earnings Per Share (EPS) | $0.43 |
Balance Sheet
The company has $17.37 million in cash and $862,408 in debt, giving a net cash position of $16.51 million or $1.40 per share.
| Cash & Cash Equivalents | 17.37M |
| Total Debt | 862,408 |
| Net Cash | 16.51M |
| Net Cash Per Share | $1.40 |
| Equity (Book Value) | 25.34M |
| Book Value Per Share | 2.15 |
| Working Capital | 20.97M |
Cash Flow
In the last 12 months, operating cash flow was $5.56 million and capital expenditures -$1.90 million, giving a free cash flow of $3.66 million.
| Operating Cash Flow | 5.56M |
| Capital Expenditures | -1.90M |
| Free Cash Flow | 3.66M |
| FCF Per Share | $0.31 |
Margins
Gross margin is 79.69%, with operating and profit margins of 24.77% and 21.48%.
| Gross Margin | 79.69% |
| Operating Margin | 24.77% |
| Pretax Margin | 28.44% |
| Profit Margin | 21.48% |
| EBITDA Margin | 28.04% |
| EBIT Margin | 26.64% |
| FCF Margin | 15.20% |
Dividends & Yields
This stock pays an annual dividend of $0.13, which amounts to a dividend yield of 1.76%.
| Dividend Per Share | $0.13 |
| Dividend Yield | 1.76% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 2 |
| Payout Ratio | 30.56% |
| Buyback Yield | 3.82% |
| Shareholder Yield | 5.58% |
| Earnings Yield | 5.85% |
| FCF Yield | 4.14% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
BioSyent has an Altman Z-Score of 16.64 and a Piotroski F-Score of 8.
| Altman Z-Score | 16.64 |
| Piotroski F-Score | 8 |